About Nutraferon Healthcare
Nutraferon Healthcare is a Healthcare company based in Hyderabad (India) founded in 2007. It manufactures nutraceuticals and super-specialty pharmaceuticals for global health markets. It operates on a B2B and D2C model. Its Indian entity Nutraferon Private Limited reported revenue of ₹3.79 Cr. Nutraferon Healthcare offers products and services including AVICTA INJECTION, METHOPLUS INJ, LIPOCALTAB, P-BIOTIC CAP, and MAGAMAX TAB. Its focus areas include Pharmaceuticals, Specialty Medicine, Clinical Treatments and Nutraceuticals.
Company details
Nutraferon Healthcare Specializes In Manufacturing And Marketing Nutraceuticals And Pharmaceuticals, Focusing On Therapeutic Areas Like Critical Care, Gastroenterology, And Gynecology. They Use Cutting-edge Facilities To Ensure Quality Products That Undergo Rigorous Clinical Testing. Based In Hyderabad, India, The Company Serves Global Customers By Shipping Products Worldwide And Prioritizing Affordable, Innovative Solutions For Health And Well-being.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nutraferon.com
- Legal Name Nutraferon Private Limited
- Date of Incorporation 24 Jan, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹3.79 Cr
FY 2025 · +104% YoY
- Net Profit₹27.3 Lakh
FY 2025 · 7% margin
- EBITDA₹50.7 Lakh
FY 2025 · 13% margin
Associated legal entities of Nutraferon Healthcare
Nutraferon Healthcare operates through Nutraferon Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nutraferon Private Limited CIN U24110TG2020PTC138698 | Active | 24 Jan 2020 | Hyderabad, Telangana | ₹3.8 Cr | 2 | View details |
Products & Services of Nutraferon Healthcare
Nutraferon Healthcare offers a comprehensive portfolio of products and services, including AVICTA INJECTION, METHOPLUS INJ, LIPOCALTAB, P-BIOTIC CAP, and MAGAMAX TAB.
Injection for critical care medical treatments
Injection used in critical health scenarios
Tablet for gynecological health support
Capsule for infection management purposes
Tablet for health supplementation needs
Board of directors of Nutraferon Private Limited (Nutraferon Healthcare)
Nutraferon Private Limited is the primary company behind Nutraferon Healthcare. The board of Nutraferon Private Limited currently have 2 directors; the longest-serving is Rachel Sadanand Chavadi, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rachel Sadanand Chavadi DIN 08679062 | Director | 24 Jan 2020 | 6 yrs 9 mo | Nutraferon Private Limited |
| Sadanand Chavadi DIN 00306910 | Director | 24 Jan 2020 | 6 yrs 9 mo | Nutraferon Private Limited |
Financials of Nutraferon Healthcare
Figures of Nutraferon Private Limited, the primary company behind Nutraferon Healthcare, for FY 2025. Revenue was ₹3.79 Cr (+104% year on year). Net profit was ₹27.3 Lakh (7% margin). EBITDA was ₹50.7 Lakh (13% margin). Revenue has grown at a compounded annual rate of +779% over three years.
- ₹3.79 CrRevenue · FY 2025 · +104% YoY
- ₹27.3 LakhNet profit · 7% margin
- ₹50.7 LakhEBITDA · 13% margin
- ₹1 LakhPaid-up capital
- +779%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nutraferon Private Limited are on its company page.
Detailed financial statements for Nutraferon Healthcare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Nutraferon Healthcare
The website of Nutraferon Healthcare (nutraferon.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 23.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nutraferon Healthcare
Nutraferon Healthcare was founded in 2007.
Nutraferon Healthcare is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Nutraferon Healthcare, Nutraferon Private Limited, reported revenue of ₹3.79 Cr for FY 2025, up 104% year on year.
Nutraferon Healthcare Specializes In Manufacturing And Marketing Nutraceuticals And Pharmaceuticals, Focusing On Therapeutic Areas Like Critical Care, Gastroenterology, And Gynecology. They Use Cutting-edge Facilities To Ensure Quality Products That Undergo Rigorous Clinical Testing. Based In Hyderabad, India, The Company Serves Global Customers By Shipping Products Worldwide And Prioritizing Affordable, Innovative Solutions For Health And Well-being.
Nutraferon Healthcare offers AVICTA INJECTION, METHOPLUS INJ, LIPOCALTAB, P-BIOTIC CAP, and MAGAMAX TAB.
Nutraferon Healthcare operates through Nutraferon Private Limited.
The legal entities of Nutraferon Healthcare currently have 2 directors, including Rachel Sadanand Chavadi, Sadanand Chavadi.